AzTrials
AzTrials

NightmaresPhase 3MARINCT01502930

Treatment of Nightmares Via the Internet

A Phase 3 study testing IRT and Stress Reduction in people with Nightmares, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a randomized controlled trial (RCT) to evaluate the effect of an internet-based, guided self-help treatment of reoccurring and distressing nightmares. Imagery Rehearsal Therapy (IRT) will be compared to an active control treatment (CONT) and a recording-only group (REG). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Nightmares
What is being tested?
IRT and Stress Reduction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
175 participants
Where
1 siteSweden
Study dates
Jan 2012to Apr 2014
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • have at least one nightmare (including awakening) or unpleasant dream (do not wake up) per week for at least a month.
  • experience significant discomfort or distress due to nightmares/unpleasant dream.
  • the content of the nightmares are not only related to a previous trauma.
  • at least 18 years
  • speaks, writes and read Swedish
  • can not foresee any practical barriers to participation.

Who cannot join

  • only suffers from night terrors and no nightmares according to criteria (a) to (c)
  • has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview.
  • somatic or psychiatric problems that are directly contraindicated or seriously hamper the implementation of the treatment (eg, psychotic disorders).
  • have severe depression, defined as MADRS-S over 30 or suicidal risk judged by more than 4 points on the MADRS-S question 9 or according to the structured telephone assessment.
  • has a total score over 76 on the IES-R (one standard deviation above the mean for individuals with a diagnosis of PTSD).
  • is diagnosed with PTSD and can not provide proof that they have a current health care contact regarding PTSD.
  • suffer from intrusive images or flashbacks during their waking hours (regardless of a PTSD diagnosis).
  • currently undergoing some form of treatment that focuses on reducing symptoms of nightmares.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO

    Stockholm

Other trials in Sweden

About this study

Official title: MARI - Treatment of Nightmares Via the Internet - a Randomized Controlled Trial

This study is a randomized controlled trial (RCT) to evaluate the effect of an internet-based, guided self-help treatment of reoccurring and distressing nightmares. Imagery Rehearsal Therapy (IRT) will be compared to an active control treatment (CONT) and a recording-only group (REG). It is hypothesized that both active treatments will be superior to REG, and that IRT will be superior to CONT.

Read the detailed description

Nightmares are distressing or frightening dreams, affecting 2.4 to 5% of the population. Suffering consists of disturbed sleep, fear and distress during night and/or day, expectancy anxiety and impaired functioning during the day.

Various forms of Cognitive Behavior Therapy (CBT) has been previously shown to be effective against nightmares and among them Imagery Rehearsal Therapy (IRT) has been the most promising. IRT consists of approaching the unpleasant dreams and to imagine a positive ending to them. So far IRT has been compared to untreated controls or treatments that have included methods to some extent similar to those in IRT, and it is therefore difficult to determine the specific effect of IRT.

Since access to CBT therapists is low, different types of self-help treatments for nightmares have been tested, but often these therapies have been provided without the assistance of a therapist, a procedure known to usually lower the effect of self-help treatments. So far, no nightmare treatment has been conducted over the Internet.

IRT will in this study be given as Internet CBT (ICBT) and will be compared to an active and credible control treatment (CONT) consisting of relaxation and exercise to focus on positive images or dreams, but without approaching or reinterpreting the nightmares. Relaxation Training has previously shown preliminary positive effects on nightmares. Both active treatments will be compared to a waiting list which only records how they manage their nightmares (REG).

The main purpose of this study is to examine whether the positive effects of IRT that has been seen in previous studies persists even when IRT is compared with a credible, active control treatment that does not contain the presumed active parts of the IRT. In addition, an untreated control group is used to ensure that the effects are not only due to spontaneous improvement. The control group will afterwards be treated with IRT without therapist support, in order to make a preliminary evaluation of the importance of therapist support.

Some researchers argue that nightmares are not to be seen only as something that is often caused or is a side effect of other conditions, but as a separate problem that should receive special treatment. Our study will help to determine whether it is possible to treat nightmares also in people with other problems such as posttraumatic stress disorder (PTSD).

Conditions
Nightmares
Being tested
IRT, Stress Reduction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IRTBehavioural

    Internet-based IRT with therapist support during 6 weeks

  • Stress ReductionBehavioural

    Internet-based stress reduction with therapist support during 6 weeks

Study groups in NCT01502930
Study groupRoleWhat they receive
IRTExperimentalImagery Rehearsal Therapy
Receives: Behavioral: IRT
CONTActive comparatorStress reduction and positive imagery
Receives: Behavioral: Stress Reduction
REGNo interventionRegistration only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in nightmare frequency and distress

    Change (from baseline) of nightmare frequency and distress according to daily registrations

    Measured: 6 weeks (Post) and 16 months (FU)

Secondary outcomes (5)
  1. Change (from baseline) in Nightmare Distress self-report

    Self-report of nightmare frequency and distress during last 14 days

    Measured: 6 weeks (Post) and 16 months (FU)

  2. Change (from baseline) in IES_R

    Impact of Events Scale, self-report to measure PTSD-symptoms

    Measured: 6 weeks (Post) and 16 months (FU)

  3. Change (from baseline) in ISI

    Insomni Severity Index, self-report to measure Insomnia symptoms

    Measured: 6 weeks (Post) and 16 months (FU)

  4. Change (from baseline) in MADRS-S

    Montgomery and Asberg Depressions Rating Scale - Self Report, to measure level of depression

    Measured: 6 weeks (Post) and 16 months (FU)

  5. Change (from baseline) in HADS

    Hospital Ancxiety and Depression Scale, self rating to measure anxiety and depression

    Measured: 6 weeks (Post) and 16 months (FU)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2012 (estimated)
  2. Study startJan 2012
  3. Primary completionApr 2014
  4. Study completionApr 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
175 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01502930
Sponsor's protocol ID
ICBT_Nightmares
Acronym
MARI
Status last verified
May 2014
First submitted
22 Dec 2011
Last updated
16 May 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing IRT and Stress Reduction in people with Nightmares, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in nightmare frequency and distress (time frame: 6 weeks (Post) and 16 months (FU)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2014; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in